Aspen’s personalized Parkinson’s therapy shows early promisenews2026-03-18T13:00:44+00:00March 18th, 2026|Endpoints News|
China mRNA therapy startup Innorna to test gout treatment in USnews2026-03-17T11:00:08+00:00March 17th, 2026|Endpoints News|
China startup CirCode gets clearance for trial of circular RNA therapynews2026-03-16T12:30:43+00:00March 16th, 2026|Endpoints News|
Ultragenyx’s gene therapy hits key endpoint in Phase 3 trial for blood ammonia diseasenews2026-03-13T14:18:51+00:00March 13th, 2026|Endpoints News|
A simpler form of DNA may be key to non-viral gene therapy, study suggestsnews2026-03-12T15:31:55+00:00March 12th, 2026|Endpoints News|
Study suggests long non-coding RNA has potential as new class of genetic medicinenews2026-03-10T20:02:18+00:00March 10th, 2026|Endpoints News|
RNA editing startup Tacit Therapeutics launches with $19M for brain diseasesnews2026-03-09T13:00:55+00:00March 9th, 2026|Endpoints News|
Tenaya wins support from Alnylam in cardio disease pactnews2026-03-05T16:06:00+00:00March 5th, 2026|Endpoints News|
China is taking on the world’s 10 most expensive medicinesnews2026-03-05T15:00:17+00:00March 5th, 2026|Endpoints News|
Prime Medicine reverses course to seek FDA approval of shelved therapynews2026-03-03T20:48:13+00:00March 3rd, 2026|Endpoints News|
